OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-03-31-accounts

The AMR Narrative Unaudited Annual Report Year Ended 31 March 2025

The AMR Narrative

Annual Report Year Ended 31 March 2025

Contents Page
Reference and Administration Details 1
Trustees’ Report 2-19
Chartered Accountant’s Report 20
Statement of Financial Activities 21
Statement of Assets and Liabilities 22
Notes and Accounting Policies 23-24

The AMR Narrative

Reference and Administration Details Year Ended 31 March 2025

Charity Name and Number

The AMR Narrative registered charity number 1204055.

Trustees

The Trustees who served during the year and up to the date of approval of these accounts were as follows:

Dr F Chiara (Chairperson) Prof M Mendelson (resigned 19 July 2024) Dr A Brink Dr O Van Hecke Dr R Coetzee Dr E Charani (resigned 26 January 2025) Dr W Thompson (resigned 4 August 2025) J P Green (appointed 17 July 2024) Prof Z Fedorowicz (appointed 13 October 2025) Dr R Freeman (appointed 13 October 2025) D Felice (appointed 13 October 2025)

Principal Address Suite 3f Peel House 30 The Downs Altrincham WA14 2PX

Bankers

Unity Trust Bank plc Four Brindleyplace Birmingham B1 2JB

Accountants

Francis Clark LLP Sigma House Oak View Close Edginswell Park Torquay Devon TQ2 7FF

1

The AMR Narrative

Trustees’ Report Year Ended 31 March 2025

Trustees Report

The trustees present their report for the year to 31 March 2025.

Objectives, Activities and Public Benefit

As per our constitution, our charitable objectives are:

Whilst our charity is registered in the UK, we prefer to take a global approach, acknowledging that antimicrobial resistance (AMR) is a worldwide issue that impacts everyone. We also understand the importance of partnerships in addressing the complexities of AMR and saving lives. This is why we are committed to fostering meaningful relationships with other patient groups, civil society leaders, academic institutions, industry stakeholders, and others.

Structure, Governance and Management Structure and Governance

The constitution requires there to be a minimum of three Trustees and there is no maximum number of charity trustees that may be appointed to the CIO.

The Founding Trustees were:

Dr Francesca Chiara (2022 – present) - Chair Dr Wendy Thompson (2022 – 2025) – Co-chair Dr Esmita Charani (2022 – 2025) Prof Adrian Brink (2022 – present) Prof Renier Coetzee (2022 – present) Dr Oliver van Hecke (2022 – present) Prof Marc Mendelson (2022 – 2024)

Resignations:

In July 2024, Prof Marc Mendelson resigned due to concerns around skills he offered to the charity, however, continues to support our work as an external advisor.

In January 2025, Dr Esmita Charani resigned due to growing work commitments, however, continues to support our work as an external advisor.

Dr Wendy Thompson resigned in August 2025 due to a perceived conflict of interest with research work she was involved with, however, continues to support our charity by promoting partnerships and funding opportunities with academic institutions. As this falls outside of the current financial year, we will include this in our 2026 report.

2

The AMR Narrative

Trustees’ Report (continued) Year Ended 31 March 2025

In 2025, we developed a skills auditing form for trustees and staff to ensure that we utilise their expertise effectively and continue to identify gaps in our board in future years.

New Appointments:

Considering our ambition to expand skills and expertise of the board, a legal trustee, Dr Jonathan Green was appointed in July 2024.

Further to this, we opened trustee applications in June 2025, whereby we had a total of 19 applicants of which 3 were appointed in October 2025, each were identified based on their strategic development, research and fundraising expertise as well as previous experience working within a non-profit board, these new Trustees are:

Prof Zbys Fedorowicz Dr Rachel Freeman Damiano de Felice

Our current Board of Trustees as of October 2025 now consists of:

Dr Francesca Chiara (2022 – present) – Chair

Prof Renier Coetzee (2022 – present) – Co-chair Prof Adrian Brink (2022 – present) Dr Oliver van Hecke (2022 – present) Prof Zbys Fedorowicz (2025 – present) Dr Rachel Freeman (2025 – present) Damiano de Felice (2025 – present) Dr Jonathan Green (2025 – present)

Management

Day-to-day operation of the charity, and implementation of its strategy, is delegated to the Executive Director, who is supported by the trustees, an external advisory, and paid consultants. In the second financial year, beginning April 2025, the Executive Director received a project-based salary through payroll and PAYE, overseen by our appointed accountants.

In September 2025, we also appointed a part-time Finance and Administration Manager, engaged as a monthly consultant, to manage daily tasks such as developing a policy register, producing ongoing financial reports, issuing invoices, and capturing monthly statements. This will be reflected further in the 2026 annual report. At present, we have not yet secured a trustee with financial expertise to act as Treasurer and therefore rely on our Finance and Administration Manager and appointed accountants.

New trustee appointments

Upon appointing new trustees, we follow a formal application process beginning with an advertisement on LinkedIn. Existing trustees are then asked to score applicants using a voting system based on their expertise and experience. The top candidates are invited for interview, and successful applicants undertake an induction during which we present an overview of the charity, recent activities, strategic objectives, and a financial summary. New trustees are also provided with our legal constitution and internal policies.

Each trustee (including the initial charity trustees) is appointed for a five-year term, with the board having the option to renew their appointment for a second five-year term at the end of the first. Should a trustee need to resign early, we request a minimum of three months’ written notice. This enables us to appoint a replacement and complete any necessary administrative procedures, particularly where the departing trustee held banking authority. This process also depends on whether the resignation would risk destabilising the board or charity operations, especially if it brings us close to the minimum required number of trustees.

3

The AMR Narrative Trustees’ Report (continued) Year Ended 31 March 2025

Chair’s Foreword

It is with pride and renewed purpose that I write this foreword for our 2024-25 Annual Report. As Chair of The AMR Narrative, I reflect on this past year of remarkable growth that has seen us evolve from a newly established charity into a more established voice in global AMR.

This past year has been transformative. Building on the strong foundations laid in our first year, we have expanded our reach and strengthened our partnerships. Our acceptance as a non-profit organisation within the WHO Civil Society Commission marks a significant step, positioning us to contribute meaningfully to international policy discussions and ensuring that patient perspectives remain central to the AMR response.

Under the continued leadership of our founder and Chief Executive, Vanessa Carter, whose lived experience and unwavering advocacy continue to guide our mission, we have delivered on ambitious projects while maintaining our commitment to evidence-based, inclusive, and people-centred work. Our Board of Trustees has been strengthened by the expertise of Prof Zbys Fedorowicz, and Drs Rachel Freeman, and Damiano de Felice, who will be supporting the Charity advancing its strategic goals across all pillars.

This year, we also focused more extensively on community outreach. Our educational resources have reached wider audiences, and our partnerships with academic institutions, patient organisations, and international bodies have deepened. We have also made important strides in diversifying our income streams, ensuring the sustainability of our work.

The challenge of AMR grows more urgent each day. Yet I am inspired by the progress we have made and the momentum we continue to build. From influencing policy at the highest levels to supporting individual patients in finding their advocacy voice, The AMR Narrative is making a tangible difference.

None of this would be possible without the extraordinary commitment of our trustees, advisors, volunteers and funders. I am also deeply grateful to all the patients who shared with us their stories and remind us daily why this work matters.

As we look to the year ahead, together, we will continue to transform the narrative around AMR, championing the voices of those most affected and working towards a world where antibiotics remain effective.

Dr Francesca Chiara

Chair, The AMR Narrative

4

The AMR Narrative

Trustees’ Report (continued) Year Ended 31 March 2025

What is antimicrobial resistance (AMR)?

AMR or Antimicrobial Resistance, is a natural phenomenon that occurs when microorganisms (germs) - such as bacteria, fungi, viruses, and parasites - evolve in ways that make the medicines designed to kill them less effective. These germs develop resistance to treatments, making infections significantly harder to cure. To understand this better, think of antimicrobials as a group of medicines designed to target various types of germs. Different antimicrobial medicines are used for different types of germs, and typically:

When germs become resistant to antimicrobial medicines, infections become more difficult to treat, leading to longer illnesses and higher risks of death (mortality) or disability (morbidity). One of the major contributors to AMR is the inappropriate use of antimicrobial medicines. For instance, antibiotics are sometimes used for illnesses like the flu, colds, and COVID-19, which are caused by viruses—not bacteria. Since antibiotics can’t kill viruses, using them for these conditions is not only ineffective but also harmful. This misuse gives germs the opportunity to become resistant to antimicrobial medicines, making future infections harder to treat. According to a recently published GRAM report (Global Report on AMR), in 2019 close to 1.3 million deaths alone were attributed to bacterial resistance to the medicines used to treat them. It has also been estimated that by 2050, more people could die from AMR than from cancer which is why it has been declared a global emergency.

Common medical-associated conditions that rely on antimicrobial medicines to work include, (not limited to):

Using a One Health approach

AMR isn't just a human health issue; it affects animals, the environment, and, ultimately, everyone. In animal farming and food production, antimicrobials are often used to prevent or treat infections in animals. However, this practice can lead to the development and spread of resistance germs in the animals and the surrounding environment. This can spread to humans in several ways—through direct contact with animals, eating contaminated meat or animal products, or through exposure to contaminated soil and water. Antifungals as an example, play a critical role in both agriculture and human health, but their use in food production can contribute to the growing problem of AMR) in humans.

5

The AMR Narrative Trustees’ Report (continued) Year Ended 31 March 2025

This is why the "One Health" approach is so important to our charity. It recognises that the health of humans, animals, and the environment are all connected, and it stresses the need for a coordinated effort across these sectors to address AMR. Consumers, the public and others are equally impacted which is why they should be included.

Charitable Objectives

As per our constitution, our charitable objectives are:

Whilst our charity is registered in the UK, we take a global approach, acknowledging that AMR is a worldwide issue that affects everyone. We also understand the importance of partnerships in addressing the complexities of AMR and saving lives. This is why we are committed to fostering meaningful relationships with other patient groups, civil society organisations, health professionals and associations, academic institutions, industry stakeholders, and others.

Founding Principles

The AMR Narrative was founded by AMR patient survivor (Vanessa Carter) and seven founding trustees. Officially registered as a Charitable Incorporated Organisation (CIO) on July 31, 2023, in the United Kingdom, it operates under its constitution. Vanessa’s advocacy journey began after spending three years battling highly resistant infections following a car accident in South Africa in 2004 and an extensive ten-year facial reconstruction. Her experience exposed critical gaps in medical systems, particularly in communication and policy, and highlighted a lack of advocacy from fellow patients, motivating her to act. In 2013, she launched her advocacy efforts. Before relocating to the UK in 2020, she envisioned a charity dedicated to empowering others facing similar challenges with AMR. This vision was realised in 2022 with the establishment of the charity.

6

The AMR Narrative Trustees’ Report (continued) Year Ended 31 March 2025

Values

We believe in upholding the highest values, because ultimately people’s lives are at stake. We focus our work on seven values which include:

  1. Compassion 2. Empowerment 3. Collaboration

  2. Integrity

  3. Equality and Inclusion

  4. Innovation

  5. Sustainability

Primary Pillars and Strategic Goals

Considering its charitable objectives, The AMR Narrative has defined its strategy around three clear strategic pillars. Although these pillars cut across all programmes of work, our activities can be categorised according to their alignment of Developing Advocacy Capacity, Promoting Public Understanding and Fostering a Global Community

Risk Management

A risk register has been created, and we plan to monitor and review it annually, considering the growth of our charity and incoming revenue.

Volunteers

A voluntary accountant was appointed on the 8th of April 2024. At present we do not have any further appointed volunteers. As we are planning to expand our community outreach in 2026, we expect to appoint further volunteers to take part in these initiatives.

External Advisory

We have 25 external advisors who provide their input on an occasional basis voluntarily. This comes in the form of writing and editing patient stories, journalism expertise to keep our news section up to date, qualified scientific writers who often contribute evidence-based content to the website. On average, the most active advisors spend 1-2 hours every 3-12 months.

7

The AMR Narrative

Trustees’ Report (continued) Year Ended 31 March 2025

Achievements, Performance and Major Activities

This second financial year, we have carried out several activities in line with our strategic objectives on a limited budget as set out in our financial report below with the aim of expanding our initiatives in the coming years.

Website development

Our website, first developed in 2022, is overseen by our Executive Director and consulting web developer and has evolved with generous support from our external advisors:

A Blog:

Our blog continues to provide clear, accessible articles on different aspects of AMR, written in plain language for patients, the public, and healthcare professionals. We receive generous contributions from scientific writers, including healthcare professionals, and each article is reviewed by both a patient and a trustee with scientific expertise to ensure accuracy and readability. In 2024–25, two key topics featured were the impact of AMR on people living with cancer, and the link between antibiotic use and C. diff. In 2025, we expanded our topics even further. The blog section can be viewed here: https://amrnarrative.org/blog

Newsletter:

Our website includes a newsletter sign-up feature, enabling users to stay connected with updates from our charity. As the subscriber base continues to grow, we aim to secure funding to launch a quarterly newsletter. As of this year, we have 379 subscribers. These are currently made up of a combination of NGOs, patients, members of the public, health professionals, researchers and others.

Personal Stories:

Our website features a “Narratives Matter” section, showcasing stories from patients who have been affected by AMR infections. This section highlights the profound impact of AMR on individuals’ lives, making this critical issue more relatable and accessible to a wider audience. It serves as a valuable resource for patients, the public, medical professionals, researchers, and policymakers, fostering greater understanding and empathy across all sectors. We have a strict data-consent process in place for patient storytellers and provide mentorship and support to those writing their stories for the first time. Stories can be viewed here: https://amrnarrative.org/narratives-matter/

News Section

In May 2024, we launched a News section on our website to provide timely updates on our activities and wider developments in AMR. Over the year, we published eight news posts, making the site more dynamic and strengthening our advocacy by regularly highlighting our initiatives and partnerships. Read our latest news here: News - The AMR Narrative

Initiatives we Support

In 2024, we created a section on our website to highlight initiatives we support. At present, these include the Antibiotic Guardian Pledge Campaign, managed by the UK Health Security Agency (UKHSA), and the AMR Symbol, hosted by the European Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI).

Subsequently, EU-JAMRAI kindly donated 200 AMR symbol badges to our charity. Whilst we are selective in promoting each external organisation’s initiative, we firmly believe in forming partnerships. These two initiatives have proven successful; therefore, we did not feel the need to duplicate such important efforts, but rather to form close ties and explore how we could work together to complement each other’s work.

8

The AMR Narrative

Trustees’ Report (continued) Year Ended 31 March 2025

Tools and Resources

Social Media Advocacy Toolkit for Antimicrobial Resistance (AMR)

In November 2024, we published a Social Media Advocacy Toolkit on The AMR Narrative website. This resource is designed to help patients, healthcare professionals, and advocates strengthen their digital advocacy efforts on AMR. The toolkit provides practical guidance and examples, and it has already begun to be used by partners worldwide. The toolkit can be downloaded here: Social Media Advocacy Toolkit for Antimicrobial Resistance (AMR) - The AMR Narrative

A-Z of AMR (Directory)

The directory is designed to provide patients, the public, medical professionals, and others with easy access to relevant information. Recognising that internet searches can often be overwhelming; we aim to offer trustworthy and easy-to-understand resources that promote a clearer understanding of AMR and related topics. All entries are written by medical professionals and moderated by a patient expert and internal scientific advisor / trustee.

In 2024 – 2025, 10 entries were added over the year, the directory remains an important long-term project. Entries in 2024 included: Vancomycin-resistant Enterococci , Methicillin-resistant Staphylococcus aureus (MRSA), Surgical Site Infection (SSI) and Carbapenem-resistant Acinetobacter baumannii (CRAB). The directory can be viewed here: https://amrnarrative.org/a-z-of-amr

Image: Screenshot of the VRE medical directory page

9

The AMR Narrative Trustees’ Report (continued) Year Ended 31 March 2025

Social media

YouTube

Our YouTube channel, launched in 2023, continues to develop as a patient-led platform for education and advocacy. In 2024–25 we expanded the channel with new content, most notably a high-end animated educational video on AMR co-created with a patient and healthcare professionals. This addition reflects our commitment to producing accessible, engaging resources that inform patients, the public and healthcare stakeholders. The channel is steadily becoming a valuable tool for extending our reach and sharing The AMR Narrative’s resources with global audiences.

Podcast Interviews

In 2024, we also conducted four interviews hosted by a patient with lived experience together with two patients, a microbiologist and non-profit UK organisation working in Sepsis. The YouTube podcast can be viewed here: https://www.youtube.com/@TheAMRNarrative

Social Media Dissemination

We maintained a consistent presence on social media throughout the year, using X, LinkedIn, Facebook and Instagram to share updates, campaigns and resources. Posts highlighted activities, patient stories and advocacy outputs, helping us to reach thousands globally and contribute to international conversations on AMR.

10

The AMR Narrative

Trustees’ Report (continued) Year Ended 31 March 2025

Public Relations

Traditional and Online Media

In 2024–25, our work and patient perspectives continued to be featured across international media outlets, helping to raise awareness of AMR and strengthen our advocacy reach. Key coverage included:

Through these outlets, our message reached diverse audiences, including the public, pharmacists, patient communities, clinicians, researchers and policy stakeholders.

11

The AMR Narrative

Trustees’ Report (continued) Year Ended 31 March 2025

Hosted Events

1. Dialogue on X.com in partnership with ReACT

In September 2024, we continued to use X as a platform for patient-led conversations on AMR. Ahead of the United Nations General Assembly for AMR, we partnered with colleagues at ReACT, to coordinate and moderate an online dialogue ( Previously known as a tweet chat) which resulted in over 1.4 million impressions during the 60-minute session and brought together 27 experts to share views around 4 questions related to “Community Leadership in tackling AMR” using the hashtag #theAMRnarrative.

2. Online Webinar Series in Partnership with the European Patients Forum (EPF)

In 2024, we co-hosted a three-part webinar series together with the European Patients Forum which focused on the importance of patient advocacy for AMR.

Watch the webinar series here. We had an average of 70 participants for each webinar.

12

The AMR Narrative

Trustees’ Report (continued) Year Ended 31 March 2025

EPF: Summer Training Course for Young Patient Advocates (STYPA)

Further to the webinar series, we delivered advocacy capacity development training at the annual European Patient’s Forum STYPA event in Brussels to 30 young patients all living with long-term medical conditions that aspire to advocate for AMR.

Participant comments on the main value of the STYPA programme included: “I can’t write everything because I learned a lot! There’s too much to say… Maybe I could answer that the expertise of Vanessa was really interesting because she gave a patient perspective and dimension that I can add to the theory that I learned with Jan and the 3 other experts of the agora!”

Read more here.

Activity and Event Participation

Events play a vital role in disseminating and promoting our work with key stakeholders and ensuring that the patient voice is represented in global AMR discussions. In 2024–25, we contributed to a range of national and international events, engaging audiences from students, patient organisations and civil society to policymakers and the wider AMR community:

Key highlights included:

Image: Vanessa Carter at the World Health Assembly, 2024

Our Executive director shared her story and more around the charity work.

13

The AMR Narrative

Trustees’ Report (continued)

Year Ended 31 March 2025

Our charity was approached to coordinate and moderate a patient panel to highlight the importance of including their voices in the innovation process for AMR to design meaningful interventions.

Image: Prof Renier Coetzee, AMR Insights virtual presentation

• FDI World Dental Federation (Nov 2024, virtual): Our Executive Director shared her lived experience of AMR with a dental audience, touching on implications which formed part of her facial reconstruction journey. The focus of the event was on Universal Health Coverage for Oral Health by 2030. • World Health Innovation Summit: Women's Health and AMR panel discussion (Nov 2024) Our Executive Director participated in an online webinar focused on women’s health where she shared her views around AMR.

• AMR Conference (Feb 2025, Basel):

Image: Dr Francesca Chiara (Chair), AMR Conference, Basel

• World Bank Group (Feb 2025, virtual):

Our Executive Director presented her story and more around the importance of promoting patient advocacy. • Wilton Park, Foreign, Commonwealth and Development Office (FCDO) (February 2025): Our Executive Director took part in a meeting hosted at Wilton Park by the FCDO to discuss and

14

The AMR Narrative

Trustees’ Report (continued) Year Ended 31 March 2025

Outcomes Statement: Reinvigorating the response to antimicrobial resistance (AMR): from aspiration to implementation

Organised by various university students in Africa, including those working in health and law, our Executive Director spoke about the value of storytelling.

The Executive Director provided a lecture to pharmacy students in relation to communication, e-Patients and AMR.

AMR – Dying to Change the World Pre-screening (March 2025, London):

Our Executive Director participated in a panel discussion with keynote speakers including former UK Chief Medical Officer (CMO) Dame Sally Davies, Alex Tweed and Lord Ara Darzi to share her views around the importance of community outreach.

Image: Vanessa Carter with Dame Sally Davies and Alex Tweed at the AMR: Dying to Change the World film premiere in London

Publications

Our charity contributed to several publications in 2024-5 helping to raise awareness, share a patient perspective, and inform policy and practice.

Patient and public involvement and engagement to improve impact on antimicrobial resistance

United Nations General Assembly (UNGA)

2024 was a crucial year for policy and AMR, with the United Nations General Assembly placing a special focus on antimicrobial resistance. The UN General Assembly High-Level Meeting on Antimicrobial Resistance took place because AMR is increasingly recognised as a mounting global threat to human, animal, and environmental health, and no single country can tackle it alone.

The AMR Narrative was delighted to have its work recognised with a special accreditation from the United Nations, enabling participation in two separate panels in New York.

Our work was also featured throughout the year as part of the lead-up to the High-Level Meeting in several ways, including:

15

The AMR Narrative

Trustees’ Report (continued)

Year Ended 31 March 2025

Our Executive Director was accepted as an opening keynote speaker at the UN Multistakeholder Meeting held in New York which had the aim to draft the political declaration on AMR. Watch the recording here.

Image: Vanessa Carter at the UN Multistakeholder Meeting, opening segment

Jointly we also submitted a Call to Action with the European Patients Forum to the United Nations for more emphasis on including patient organisations and patient voices to tackle AMR here.

16

The AMR Narrative

Trustees’ Report (continued) Year Ended 31 March 2025

World AMR Awareness Week (WAAW)

World Antimicrobial Resistance (AMR) Awareness Week (18-24 November) matters because it shines a global spotlight on one of the most urgent health threats of our time. Led by the World Health Organization (WHO) and its partners, it raises public understanding of AMR, encourages responsible use of antibiotics and other antimicrobial medicines, and highlights the impact of resistance on patients, healthcare systems, and communities worldwide. For healthcare professionals, policymakers, and patient organisations, the week provides a platform to share knowledge, showcase research and patient stories, and drive coordinated action. Ultimately, it helps to mobilise collective efforts to preserve the effectiveness of life-saving treatments for current and future generations.

During WAAW 2024, we participated in a coordinated programme of activities across multiple platforms to raise awareness and strengthen patient-led advocacy.

Highlights included:

Together, these activities showcased our ability to engage diverse audiences, from healthcare professionals to policymakers, the media and the wider public.

Outlook

We are still a young charity, and although we have very few resources, we continue to work hard towards our strategic goals and raising funds to achieve them. We have ambitious projects underway, although we hope to focus more extensively on community outreach in 2026.

In mid-2025, we were formally accepted as a non-profit organisation within the WHO Civil Society Commission, which we will report on in our next financial year. In addition, we are placing greater emphasis on diversifying our income streams and have engaged in discussions with several new organisations, including those from the academic sector, regarding potential research-focused projects. We have also sought mentorship from longestablished and respected charities with which we work, to help us better understand and achieve these goals.

17

The AMR Narrative

Trustees’ Report (continued)

Year Ended 31 March 2025

Financial Review and Reserves Policy

Financial Review

Income for the year amounted to £35,884. This was made up of grant income totalling £30,055 and speaker/appearance fees of £5,829.

Expenditure for the year, including expenses incurred in relation to the registration and creation of the charity totalled £29,641. This was made up of expenditure for charitable activities and fundraising events totalling £11,108, £1,360 for insurance, and management, professional and administration fees (including salaries) of £17,173.

A surplus of £6,243 was generated and unrestricted funds carried forward total £18,227.

Reserves Policy

We have developed a reserves policy. The target level of reserves will be reviewed annually by the Board of Trustees. At present, our reserves policy stipulates that we require at least six months of operational expenditure. This level is deemed sufficient to cover potential shortfalls in income and unexpected expenses as we continue to grow.

Statement of Trustees’ Responsibilities

The Trustees are responsible for preparing the Trustees’ Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

The law applicable to charities in England and Wales requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the Charity and of the incoming resources and application of resources of the Charity for that period.

18

The AMR Narrative Trustees’ Report (continued) Year Ended 31 March 2025

In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the Charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations and the provisions of the Trust Deed. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Signed on behalf of the Trustees on 13/01/2026 by:

Dr F Chiara

Chairperson and trustee

Dr Renier Coetzee Co-chair and trustee

19

The AMR Narrative

Independent Examiner’s Report Year Ended 31 March 2025

Independent examiner’s report to the Trustees of The AMR Narrative

I report to the charity Trustees on my examination of the accounts of the Charity for the year ended 31 March 2025.

Responsibilities and basis of report

"As the charity’s Trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’).

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act. "

Independent examiner’s statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

  1. accounting records were not kept in respect of the Charity as required by section 386 of the 2006 Act; 2. the accounts do not accord with those records; or

  2. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an independent examination; or

  3. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Martin Hobbs BSc ACA Francis Clark LLP Sigma House Oak View Close Edginswell Park Torquay TQ2 7FF

13 January 2026

………………………....

20

The AMR Narrative

Statement of Financial Activities Year Ended 31 March 2025

Income from:
Grants
Other income
Expenditure on:
Charitable activities
- Charitable activities and fundraising events
- Insurance
- Management and administration
- Salaries
Net income/(expenditure)
Reconciliation of funds
Total funds brought forward
Total unrestricted funds carried forward
Notes
3
4
5
6
7		 2025
£
30,055
5,829
35,884
11,108
1,360
6,144
11,029
29,641
6,243
11,984
18,227		 2024
£
16,711
444
17,155
-
405
421
4,345
5,171
-
11,984
11,984

21

The AMR Narrative

Balance Sheet

Year Ended 31 March 2025

Current assets
Cash at bank and in hand
Debtors
Creditors: amounts falling due within one year
Trade creditors
Accruals
Amounts Owed to Related Parties
Net current assets and total net assets
The funds of the Charity
Unrestricted funds
Notes
8		 -
2025
£
7,559
16,612
24,171
2,400
3,544
5,944
18,227
18,227		 -
2024
£
16,981
16,981
452
1,200
3,345
4,997
11,984
11,984

The notes on pages 7 to 8 form part of these accounts.

Approved by the Trustees on 13/01/2026 and signed on their behalf by:

Dr F Chiara Chairperson

Dr Renier Coetzee (Co-chair) Trustee

Ms V Carter Executive Director

22

The AMR Narrative

Notes and Accounting Policies Year Ended 31 March 2025

1. General Information

The AMR Narrative is a registered charitable incorporated organisation, registered under the number 1204055, and was established under a scheme of the Charity Commissioners dated 20 July 2023.

Its registered office and principal address is: Suite 3f

Peel House

30 The Downs

Altrincham WA14 2PX

2. Accounting Policies

a) Basis of preparation and assessment of going concern

The financial statements have been prepared under the historical cost convention, with items recognised at cost or transaction value unless otherwise stated in the relevant note(s) to these financial statements. The financial statements have been prepared in accordance with the Statement of Recommended Practice “Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) Second Edition 2019 and the Charities Act 2011.

The accounts have been presented in sterling and rounded to the nearest £.

The trust constitutes a public benefit entity as defined by FRS 102.

The trustees consider that there are no material uncertainties about the Charity’s ability to continue as a going concern.

The following principal accounting policies have been applied.

b) Income recognition

All income is recognised once the charity has entitlement to the income, there is sufficient certainty of receipt and so it is probable that the income will be received, and the amount of income receivable can be measured reliably.

c) Expenditure recognition

All expenditure is accounted for on an accruals basis and includes irrecoverable VAT. All expenses including support costs and governance costs are allocated to charitable activities.

Costs of Charitable activities include costs incurred directly on achieving the objects of the Charity, and governance costs.

23

The AMR Narrative

Notes and Accounting Policies (continued) Year Ended 31 March 2025

3.
4.
5.
6.
7.
Grant Income
BioMerieux SA Grant
Cephied UK Ltd Grant
Other Income
World AMR Awareness Week Speaker Fee
Donations
European Patients Forum
Charitable activities and fundraising events
Promotional video for educational grant
Donation platform subscription
Management and Administration
Accountancy fees
Professional fees
Bank fees
IT Software and Website Maintenance
Training costs
General Expenses
Travel - International & National
Staff Costs
Salaries
Employers National Insurance		 2025
£
14,055
16,000		 2024
£
16,711
-
30,055 16,711
2025
£
1,600
129
4,100		 2024
£
444
-
-
5,829 444
2025
£
10,569
539		 2024
£
363
42
11,108 405
2025
£
3,869
836
268
128
65
218
760		 2024
£
1,620
1,512
56
1,094
63
-
-
6,144 4,345
2025
£
10,420
609		 2024
£
-
-
11,029 -

8. Trustees and Other Related Parties

No trustee or connected persons have received any remuneration or reimbursed expenses.

During the prior year, the Executive Director incurred start up expenditure on behalf of the charity.These costs amounting to £3,345 were recognised in the prior year. Further accountancy subscription costs have been added totalling £199. The total due to the Executive Director as at 31 March 2025 is £3,544.

There were no other related party transactions.

24